fda warning bpc-157 unapproved peptide safety risk Issues Warning: Compounding Certain Bulk Drug Substances May Pose Major Legal and Patient Risks fda warning bpc-157 unapproved peptide
Description
Mol Med (2007) 13(7-8):41521
PubMed Rosenstock J, et al
Mark Cohen or Dr
Look for suppliers providing: Third-party testing through independent laboratories confirming peptide identity and purity, ideally showing 98%+ purity via HPLC analysis
